Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CUE | AMGN | VRTX | REGN | GILD |
| Company | Cue Biopharma Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.7900 | 322.48 | 507.17 | 826.57 | 96.05 |
| High | 1.8700 | 328.25 | 519.88 | 830.73 | 97.32 |
| Low | 1.6400 | 321.37 | 504.94 | 822.80 | 94.91 |
| Last | 1.7200 | 325.28 | 516.74 | 829.23 | 96.57 |
| Change | -0.0600 | +3.37 | +14.29 | +4.75 | -1.33 |
| % Change | -3.37% | +1.05% | +2.84% | +0.58% | -1.36% |
| Volume | 546,591 | 1,890,526 | 1,220,789 | 556,161 | 7,371,343 |
| 20-Day Average Volume | 834,465 | 1,849,711 | 1,114,514 | 803,733 | 5,987,892 |
| Previous Close | 1.7800 | 321.91 | 502.45 | 824.48 | 97.90 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.5155 | 319.58 | 483.26 | 917.55 | 89.04 |
| 20-Day Raw Stochastic | 76.16% | 83.14% | 94.47% | 7.45% | 87.45% |
| 20-Day Relative Strength | 61.59% | 54.16% | 64.99% | 21.66% | 76.24% |
| Weighted Alpha | -60.38 | +19.80 | +38.80 | -9.95 | +40.04 |
| Today's Opinion | 56% Buy | 40% Buy | 88% Buy | 72% Sell | 100% Buy |
| Previous Opinion | 56% Buy | 8% Buy | 88% Buy | 56% Sell | 100% Buy |
| Last Month's Opinion | 8% Sell | 40% Buy | 40% Buy | 24% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +13.16% since 11/01/24 | +1.90% since 11/01/24 | +9.68% since 11/01/24 | -1.70% since 11/01/24 | +7.88% since 11/01/24 |
| Low | 1.3200 on 11/05/24 | 313.02 on 11/05/24 | 468.77 on 11/04/24 | 813.53 on 11/06/24 | 89.01 on 11/05/24 |
| High | 1.9000 on 11/07/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 852.01 on 11/04/24 | 98.32 on 11/07/24 |
| 1-Month | |||||
| %Chg | +39.84% since 10/08/24 | +2.39% since 10/08/24 | +12.59% since 10/08/24 | -17.51% since 10/08/24 | +13.33% since 10/08/24 |
| Low | 0.7100 on 10/09/24 | 310.63 on 10/30/24 | 456.16 on 10/09/24 | 813.53 on 11/06/24 | 84.17 on 10/11/24 |
| High | 1.9500 on 10/29/24 | 329.17 on 10/11/24 | 519.88 on 11/08/24 | 1,024.36 on 10/15/24 | 98.32 on 11/07/24 |
| 3-Month | |||||
| %Chg | +160.57% since 08/08/24 | +0.18% since 08/08/24 | +10.90% since 08/08/24 | -25.52% since 08/08/24 | +27.75% since 08/08/24 |
| Low | 0.4500 on 09/26/24 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 813.53 on 11/06/24 | 72.43 on 08/12/24 |
| High | 1.9500 on 10/29/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 1,211.20 on 08/27/24 | 98.32 on 11/07/24 |
| 6-Month | |||||
| %Chg | -9.95% since 05/08/24 | +5.85% since 05/08/24 | +23.38% since 05/08/24 | -13.24% since 05/08/24 | +48.74% since 05/08/24 |
| Low | 0.4500 on 09/26/24 | 295.30 on 06/13/24 | 416.03 on 05/09/24 | 813.53 on 11/06/24 | 62.07 on 05/31/24 |
| High | 1.9899 on 05/10/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 1,211.20 on 08/27/24 | 98.32 on 11/07/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 86,585 | 173,037,264 | 129,395,448 | 90,602,096 | 121,884,712 |
| Shares Outstanding, K | 48,643 | 537,533 | 257,529 | 109,890 | 1,244,992 |
| Annual Sales | 5,490,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -50,730,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 2,660,000 | 8,503,000,000 | 2,645,600,000 | 3,720,700,000 | 6,954,000,000 |
| Last Quarter Net Income | -10,170,000 | 2,830,000,000 | -3,593,600,000 | 1,340,600,000 | 1,614,000,000 |
| 60-Month Beta | 1.80 | 0.60 | 0.39 | 0.15 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.20 on 08/14/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 12.46 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/14/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.74 | 0.00 | 20.43 | 20.70 |